NCT02636361View on ClinicalTrials.gov

A Study of Various Formulations of LY900014 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Healthy
Interventions
DRUG

LY900014

Administered subcutaneously (SC)

DRUG

Insulin lispro (Humalog)

Administered SC

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02636361 - A Study of Various Formulations of LY900014 in Healthy Participants | Biotech Hunter | Biotech Hunter